VEBRELTINIB

UNII:	2WZP8A9VFN
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₀H₁₅F₃N₈
Preferred Substance Name:	VEBRELTINIB
InChIKey:	QHXLXUIZUCJRKV-UHFFFAOYSA-N
GSRS Full Record:	2WZP8A9VFN i

1440964-89-5
1,2,4-TRIAZOLO(4,3-B)PYRIDAZINE, 6-(1-CYCLOPROPYL-1H-PYRAZOL-4-YL)-3-(DIFLUORO(6- FLUORO-2-METHYL-2H-INDAZOL-5-YL)METHYL)-
6-(1-CYCLOPROPYL-1H-PYRAZOL-4-YL)-3-(DIFLUORO(6-FLUORO-2-METHYL-2H-INDAZOL-5- YL)METHYL)-1,2,4-TRIAZOLO(4,3-B)PYRIDAZINE
6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine
APL-101
BOZITINIB
CBI-3103
CBT-101
PLB-1001
VEBRELTINIB [USAN]
Vebreltinib [WHO-DD]
vebreltinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VEBRELTINIB

Synonyms and Mappings

Resources